Regeneron Pharmaceuticals (REGN) Insider Trading & Ownership $738.00 -6.50 (-0.87%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Regeneron Pharmaceuticals (NASDAQ:REGN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.48%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)11Amount OfInsider Selling(Last 12 Months)$105.64 M Get REGN Insider Trade Alerts Want to know when executives and insiders are buying or selling Regeneron Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address REGN Insider Buying and Selling by Quarter Ad DTII've got news for you… Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the weekwatch this FREE briefing with me and expert trader Graham Lindman Regeneron Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/23/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$941.39$1,001 - $15,00010/15/2024Greg LandsmanU.S. Congress Member (D-OH)Sell$1,016.53$1,001 - $15,0008/28/2024Christopher R FenimoreCFOSell5,680$1,205.33$6,846,274.40 8/7/2024Jason PitofskyVPSell487$1,070.00$521,090.00 7/11/2024Joseph J LarosaEVPSell1,866$1,088.95$2,031,980.70 7/1/2024Arthur F RyanDirectorSell100$1,059.24$105,924.00 7/1/2024Marion MccourtEVPSell1,137$1,047.11$1,190,564.07 7/1/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$1,057.02$1,001 - $15,0006/24/2024Bonnie L BasslerDirectorSell756$1,062.00$802,872.00 Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW6/14/2024Michael S BrownDirectorSell1,535$1,040.00$1,596,400.00 6/11/2024Leonard S SchleiferCEOSell9,064$1,015.43$9,203,857.52 6/6/2024Leonard S SchleiferCEOSell787$1,015.02$798,820.74 6/5/2024Bonnie L BasslerDirectorSell827$1,011.00$836,097.00 5/28/2024Michael S BrownDirectorSell1,172$974.86$1,142,535.92 5/17/2024Leonard S SchleiferCEOSell22,830$979.23$22,355,820.90 5/14/2024Leonard S SchleiferCEOSell25,000$979.25$24,481,250.00 4/4/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$937.02$1,001 - $15,0003/14/2024Andrew J MurphyEVPSell5,783$956.47$5,531,266.01 3/1/2024Arthur F RyanDirectorSell100$982.05$98,205.00 3/1/2024Marion MccourtEVPSell358$967.50$346,365.00 2/26/2024Bonnie L BasslerDirectorSell854$979.25$836,279.50 2/22/2024Joseph J LarosaEVPSell1,000$967.65$967,650.00 2/8/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$946.43$1,001 - $15,0002/7/2024Joseph J LarosaEVPSell1,000$950.00$950,000.00 2/5/2024Marion MccourtEVPSell1,000$934.71$934,710.00 2/1/2024Arthur F RyanDirectorSell100$954.22$95,422.00 1/30/2024Bonnie L BasslerDirectorSell827$959.00$793,093.00 1/23/2024Joseph L GoldsteinDirectorSell2,707$950.00$2,571,650.00 1/17/2024Jonathan L. JacksonU.S. Congress Member (D-IL)Buy$929.13$1,001 - $15,0001/2/2024George YancopoulosInsiderSell16,848$900.00$15,163,200.00 12/27/2023Christopher R FenimoreSVPSell2,448$856.71$2,097,226.08 12/27/2023Michael S BrownDirectorSell2,049$898.00$1,840,002.00 12/21/2023Christopher R FenimoreSVPSell1,680$844.01$1,417,936.80 12/1/2023Arthur F RyanDirectorSell100$817.30$81,730.00 (Data available from 1/1/2013 forward) REGN Insider Trading Activity - Frequently Asked Questions Who is on Regeneron Pharmaceuticals's Insider Roster? The list of insiders at Regeneron Pharmaceuticals includes Andrew J Murphy, Arthur F Ryan, Bonnie L Bassler, Christine A Poon, Christopher R Fenimore, George L Sing, George Yancopoulos, Huda Y Zoghbi, Jason Pitofsky, Joseph J Larosa, Joseph L Goldstein, Leonard S Schleifer, Marc Tessier-Lavigne, Marion Mccourt, Michael S Brown, N Anthony Coles, Neil Stahl, Plew Daniel P Van, Robert E Landry. Learn more on insiders at REGN. What percentage of Regeneron Pharmaceuticals stock is owned by insiders? 7.48% of Regeneron Pharmaceuticals stock is owned by insiders. Learn more on REGN's insider holdings. Which Regeneron Pharmaceuticals insiders have been selling company stock? The following insiders have sold REGN shares in the last 24 months: Andrew J Murphy ($5,531,266.01), Arthur F Ryan ($841,141.00), Bonnie L Bassler ($6,627,996.50), Christine A Poon ($10,314,831.60), Christopher R Fenimore ($12,129,219.52), George Yancopoulos ($28,655,829.68), Huda Y Zoghbi ($850,000.00), Jason Pitofsky ($521,090.00), Joseph J Larosa ($3,949,630.70), Joseph L Goldstein ($5,462,050.00), Leonard S Schleifer ($56,839,749.16), Marion Mccourt ($7,173,861.45), Michael S Brown ($7,030,834.32), N Anthony Coles ($4,111,845.38), Neil Stahl ($9,810,031.70), Plew Daniel P Van ($5,216,076.87), and Robert E Landry ($1,496,786.36). How much insider selling is happening at Regeneron Pharmaceuticals? Insiders have sold a total of 183,400 Regeneron Pharmaceuticals shares in the last 24 months for a total of $166,562,240.25 sold. Which members of congress are trading Regeneron Pharmaceuticals? Jonathan L. Jackson (D-IL) has bought shares of Regeneron Pharmaceuticals in the last year totaling $8,000. Josh Gottheimer (D-NJ), Greg Landsman (D-OH), and Tommy Tuberville (R-AL) have sold shares totaling $40,000. Regeneron Pharmaceuticals Key ExecutivesDr. Leonard S. Schleifer M.D. (Age 71)Ph.D., Co-Founder, President, CEO & Co-Chairman Compensation: $8.18M2 recent tradesDr. George D. Yancopoulos M.D. (Age 64)Ph.D., Co-Founder, President, Chief Scientific Officer & Co-Chairman Compensation: $7.76MDr. Andrew J. Murphy Ph.D. (Age 65)Executive Vice President of Research Compensation: $1.68MMr. Daniel P. Van Plew (Age 51)Executive VP and GM of Industrial Operations & Product Supply Compensation: $2.01MMr. Christopher R. Fenimore CPA (Age 53)Senior VP of Finance & CFO 1 recent tradesMs. Patrice GiloolySenior Vice President of Quality Assurance & OperationsMr. Bob McCowanSenior VP of IT & Chief Information OfficerMr. Ryan CroweSenior Vice President of Investor Relations & Strategic AnalysisMr. Joseph J. LaRosa (Age 65)Executive VP, General Counsel & Secretary Compensation: $1.75M1 recent tradesMs. Melissa LoznerSenior VP & Chief Compliance Officer More Insider Trading Tools from MarketBeat Related Companies BGNE Insider Transactions RPRX Insider Transactions CTLT Insider Transactions AMGN Insider Transactions VRTX Insider Transactions GILD Insider Transactions ALNY Insider Transactions BIIB Insider Transactions UTHR Insider Transactions INCY Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:REGN) was last updated on 11/25/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regeneron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
